Ribavirin in respiratory syncytial virus infection. A double blind placebo controlled trial is needed.
D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011897:Random Allocation; D012136:Respiratory Syncytial Viruses; D010253:Respirovirus Infections / Q000188:drug therapy*; D012254:Ribavirin / Q000627:therapeutic use*; D012263:Ribonucleosides / Q000627:therapeutic use*; D012307:Risk Factors
D012263:Ribonucleosides; D012254:Ribavirin